| EQA 2027 - Glomerular filtration rate (GFR) and chronic kidney disease (CKD) evaluation (CLAI) |
|---|
|
Expert Biologists - Program Coordinators:
Bernard POGGI, Sabine ZAEPFEL, Estelle BUGNI and Patric DELISLE EQA performed since 2008
Number of analytical sites registered in 2026: 220 |
| Program organised by ProBioQual and placed under the aegis of the FAEEQ |
|
1 – Program overview
This external quality assessment program assesses the accuracy of quantitative methods for serum creatinine, urinary creatinine, urinary albumin (microalbumin) and cystatin C. It also evaluates the different clearance calculations performed (with the exception of the MDRD formula).
Participating labs can choose to be assessed for all the analytes of this program, or simply a subset of analytes of interest.
2 – Assessment frequency
Number of surveys per year: 5
Number of control samples per survey: 2 (1 serum sample and 1 urine sample) or 4 (2 serum samples and 2 urine samples)
Number of samples per year: 14 (6 lyophilised serum and 6 lyophilised urine samples + 1 fresh serum and 1 fresh urine sample)
3 – List of analytes assessed
4 – Description of the control samples
Lyophilised human control serum and urine (6 serum samples and 6 urine samples to be resuspended in 1 mL of distilled water).
1 fresh serum and 1 fresh urine, control of human origin (ready-to-use, 0.5 mL of serum and 1.5 mL of urine).
5 – Demographic data
The patient’s demographic data (sex, ethnic origin, weight, age) and diuresis rate are provided in the technical notes of the program.
| | Legal notices and privacy policy | General Terms of Sale | | Last updated: 17 September 2026 | Copyright © 2011-2026 ProBioQual All rights reserved. |